Results 11 to 20 of about 1,895 (152)

When BAT Precedes BIG‐IV in Infant Botulism: The Need for Structured Antitoxin Decision‐Pathway Reporting in Case Reports [PDF]

open access: yesClinical Case Reports
In infant botulism, use of equine‐derived botulinum antitoxin before BIG‐IV may be clinically justified when the infant‐specific product is delayed.
Muhammad Abdullah Awan   +1 more
doaj   +3 more sources

Infant Botulism, Israel, 2007–2021 [PDF]

open access: yesEmerging Infectious Diseases, 2023
Infant botulism (IB) is an intestinal toxemia that manifests as descending paralysis, constipation, and, in some cases, respiratory failure. Laboratory-confirmed IB cases are rare, and recent data in Israel are lacking.
Bar Goldberg   +12 more
doaj   +2 more sources

Genomic Characterization of Strains From a Cluster of Infant Botulism Type A in a Small Town in Colorado, United States [PDF]

open access: yesFrontiers in Microbiology, 2021
Three cases of infant botulism were reported in a small Colorado town between 1981 and 1984. The first two cases occurred in 1981, 6 months apart, and the third case occurred in 1984. Clostridium botulinum type A was isolated from stool of all three case
Lori Gladney   +2 more
doaj   +2 more sources

Infant botulism. [PDF]

open access: yesEurasian J Med, 2010
Infant botulism is a rare condition caused by intestinal colonization with Clostridium botulinum. The enteric toxin causes intestinal immobility and progressive descending paralysis due to the effect on acetylcholine release at the neuromuscular junction and other cholinergic nerve terminals, particularly in the gut.
Cagan E, Peker E, Dogan M, Caksen H.
europepmc   +3 more sources

First case of infant botulism in Sicily—case report [PDF]

open access: yesItalian Journal of Pediatrics
Background Botulism is a rare and life-threatening disease caused by the potent botulinum neurotoxin (BoNT), which can be produced by Clostridium botulinum (C. botulinum) and related bacteria.
Antonino Fazzino   +9 more
doaj   +2 more sources

Infant botulism in Singapore. [PDF]

open access: yesSingapore Med J, 2020
Charan N   +9 more
europepmc   +4 more sources

The unsung hero: ntnh gene as complementary botulism marker [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
Botulism is a rare but severe neurological disease caused by botulinum neurotoxins (BoNTs). Standard diagnostic methods including the mouse bioassay (SMB) and bont gene type-specific PCR, are often limited by the high genetic diversity among bont ...
Sylvia Valdezate   +9 more
doaj   +2 more sources

Infant Botulism: A Case Study in Integrated Clinical and Public Health Response. [PDF]

open access: yesClin Case Rep
ABSTRACT Early recognition of constipation, feeding difficulty, and descending weakness in infants is vital for prompt diagnosis of infant botulism. Bedside nerve studies support early treatment. Rapid public health notification and coordinated access to specific therapies, including timely use of BAT and BIG‐IV, are essential to optimize outcomes and ...
Gannon J   +10 more
europepmc   +2 more sources

Denmark: Botulism in an infant or infant botulism? [PDF]

open access: yesEurosurveillance, 2008
A 4.5 months old, previously healthy Danish girl was admitted to a paediatric department after six days of passive behaviour and weak suck. Over the next days she became increasingly weak, developed bilateral ptosis, the muscle stretch reflexes were lost, and mydriasis with slow pupillary responses was noted.
A, Paerregaard   +5 more
openaire   +2 more sources

First confirmed case of infant botulism in Africa, caused by a dual-toxin-producing Clostridium botulinum strain

open access: yesInternational Journal of Infectious Diseases, 2021
Botulism, a rare life-threatening toxemia, is probably underdiagnosed in all of its forms in Africa. This study reports the first laboratory-supported case of infant botulism on the African continent.
Marné N. Vosloo   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy